1800-272-662
Shopping Cart 0
countryflagAU
Login

Epiminder Ltd

Healthcare AU EPI

0.74AUD
-0.04(5.13%)

Last update at 2026-03-12T04:41:00Z

Day Range

0.700.74
LowHigh

52 Week Range

0.771.49
LowHigh

Fundamentals

  • Previous Close 0.78
  • Market Cap142.78M
  • Volume15416
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-31.16458M
  • Revenue TTM0.65M
  • Revenue Per Share TTM0.008
  • Gross Profit TTM 0.65M
  • Diluted EPS TTM-0.2

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30
Type yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30
Income before tax -34.51301M -22.39029M -21.34097M
Minority interest - - -
Net income -34.51301M -22.39029M -21.34097M
Selling general administrative 8.93M 5.99M 6.11M
Selling and marketing expenses - - -
Gross profit - - -
Reconciled depreciation 0.07M 0.09M 0.08M
Ebit - - -
Ebitda - - -
Depreciation and amortization - - -
Non operating income net other - - -
Operating income -28.59232M -21.07553M -20.63552M
Other operating expenses - - -
Interest expense 3.04M 1.95M 1.01M
Tax provision 0.00000M 0.00000M 0.00000M
Interest income - - -
Net interest income -3.04476M -1.95191M -1.01125M
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense - - -
Total revenue - - -
Total operating expenses - - -
Cost of revenue - - -
Total other income expense net -2.87593M 0.64M 0.31M
Discontinued operations - - -
Net income from continuing ops -34.51301M -22.39029M -21.34097M
Net income applicable to common shares - - -
Preferred stock and other adjustments - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30
Type yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30
Total assets 130.71M 0.00000M 0.00000M
Intangible assets 13.15M - -
Earning assets - - -
Other current assets 0.15M - -
Total liab 23.32M 0.00000M 0.00000M
Total stockholder equity 107.39M 0.00000M 0.00000M
Deferred long term liab - - -
Other current liab - - -
Common stock - - -
Capital stock 207.78M - -
Retained earnings -110.73500M - -
Other liab - - -
Good will - - -
Other assets - - -
Cash 116.95M - 0.00000M
Cash and equivalents - - -
Total current liabilities 23.21M 0.00000M 0.00000M
Current deferred revenue - - -
Net debt - - -
Short term debt - - -
Short long term debt - - -
Short long term debt total - - -
Other stockholder equity - - -
Property plant equipment - - -
Total current assets 117.49M 0.00000M 0.00000M
Long term investments - - -
Net tangible assets - - -
Short term investments - - -
Net receivables 0.38M - -
Long term debt - - -
Inventory - - -
Accounts payable 22.64M - -
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total 13.22M 0.00000M 0.00000M
Capital lease obligations - - -
Long term debt total - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30
Type yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30
Investments - - -
Change to liabilities - - -
Total cashflows from investing activities - - -
Net borrowings 14.58M 8.44M 7.56M
Total cash from financing activities 14.58M 13.98M 10.38M
Change to operating activities - - -
Net income -34.51301M -22.39029M -21.34097M
Change in cash -2.43814M 0.16M -3.89794M
Begin period cash flow 11.31M 11.17M 15.09M
End period cash flow 8.85M 11.31M 11.17M
Total cash from operating activities - - -
Issuance of capital stock - 5.54M 2.82M
Depreciation - - -
Other cashflows from investing activities - - -
Dividends paid - - -
Change to inventory - - -
Change to account receivables - - -
Sale purchase of stock - - -
Other cashflows from financing activities - - -
Change to netincome - - -
Capital expenditures 0.00000M 0.00000M 0.00000M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital - - -
Stock based compensation - - -
Other non cash items - - -
Free cash flow - - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
EPI
Epiminder Ltd		 -0.04 5.13% 0.74 - - 220.27 0.002
COH
Cochlear Ltd		 -4.25 2.32% 179.16 35.04 28.33 5.17 6.50 5.41 22.39
4DX
4DMEDICAL Ltd		 -0.16 3.65% 4.22 - - 421.18 37.59 411.50 -7.2899
AVR
Anteris Technologies Global Corp		 0.24 2.71% 9.10 - - 495.24 162.25 283.45 -5.1986
PNV
Polynovo Ltd		 -0.01 1.05% 0.94 92.50 30.40 4.58 7.52 4.45 89.43

Reports Covered

Stock Research & News

View All

Profile

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder app that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder cloud for processing; and Minder cloud, a secure, online portal which allows healthcare professionals to download patient data. Epi-Minder Pty Ltd was incorporated in 2017 and is based in Melbourne, Australia.

Epiminder Ltd

West Podium, Mezzanine 2, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Dr. Rohan J. Hoare Ph.D. CEO, MD & Director 1964
Prof. Mark Cook A.O. Founder & Chief Medical Officer NA
Mr. Mark McLellan CFO & Company Secretary NA
Dr. John Heasman Chief Operating Officer NA
Mr. Toby McSweeney CTO & VP of Quality NA
Ms. Karen Campitelli Company Secretary NA
Ms. Belinda Ann Cleminson BEd, GIA (Cert) Joint Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.